These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

103 related items for PubMed ID: 25339700

  • 1. Human liver-type fatty acid-binding protein protects against tubulointerstitial injury in aldosterone-induced renal injury.
    Ichikawa D, Kamijo-Ikemori A, Sugaya T, Shibagaki Y, Yasuda T, Hoshino S, Katayama K, Igarashi-Migitaka J, Hirata K, Kimura K.
    Am J Physiol Renal Physiol; 2015 Jan 15; 308(2):F114-21. PubMed ID: 25339700
    [Abstract] [Full Text] [Related]

  • 2. Renal liver-type fatty acid binding protein attenuates angiotensin II-induced renal injury.
    Ichikawa D, Kamijo-Ikemori A, Sugaya T, Yasuda T, Hoshino S, Igarashi-Migitaka J, Hirata K, Kimura K.
    Hypertension; 2012 Oct 15; 60(4):973-80. PubMed ID: 22926951
    [Abstract] [Full Text] [Related]

  • 3. Liver-type fatty acid-binding protein attenuates renal injury induced by unilateral ureteral obstruction.
    Kamijo-Ikemori A, Sugaya T, Obama A, Hiroi J, Miura H, Watanabe M, Kumai T, Ohtani-Kaneko R, Hirata K, Kimura K.
    Am J Pathol; 2006 Oct 15; 169(4):1107-17. PubMed ID: 17003471
    [Abstract] [Full Text] [Related]

  • 4. Amelioration of diabetic tubulointerstitial damage in liver-type fatty acid-binding protein transgenic mice.
    Kamijo-Ikemori A, Sugaya T, Sekizuka A, Hirata K, Kimura K.
    Nephrol Dial Transplant; 2009 Mar 15; 24(3):788-800. PubMed ID: 18854419
    [Abstract] [Full Text] [Related]

  • 5. Renoprotective effect of renal liver-type fatty acid binding protein and angiotensin II type 1a receptor loss in renal injury caused by RAS activation.
    Ichikawa D, Kamijo-Ikemori A, Sugaya T, Shibagaki Y, Yasuda T, Katayama K, Hoshino S, Igarashi-Migitaka J, Hirata K, Kimura K.
    Am J Physiol Renal Physiol; 2014 Mar 15; 306(6):F655-63. PubMed ID: 24431207
    [Abstract] [Full Text] [Related]

  • 6. Protective effects of tubular liver-type fatty acid-binding protein against glomerular damage in murine IgA nephropathy.
    Zuo N, Suzuki Y, Sugaya T, Osaki K, Kanaguchi Y, Wang L, Tomino Y.
    Nephrol Dial Transplant; 2011 Jul 15; 26(7):2127-37. PubMed ID: 21109611
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Aldosterone/NaCl-induced renal and cardiac fibrosis is modulated by TGF-β responsiveness of T cells.
    Schreier B, Rabe S, Schneider B, Ruhs S, Grossmann C, Hauptmann S, Blessing M, Neumann J, Gekle M.
    Hypertens Res; 2011 May 15; 34(5):623-9. PubMed ID: 21346767
    [Abstract] [Full Text] [Related]

  • 10. Urinary excretion of fatty acid-binding protein reflects stress overload on the proximal tubules.
    Kamijo A, Sugaya T, Hikawa A, Okada M, Okumura F, Yamanouchi M, Honda A, Okabe M, Fujino T, Hirata Y, Omata M, Kaneko R, Fujii H, Fukamizu A, Kimura K.
    Am J Pathol; 2004 Oct 15; 165(4):1243-55. PubMed ID: 15466390
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Protective effects of L-type fatty acid-binding protein (L-FABP) in proximal tubular cells against glomerular injury in anti-GBM antibody-mediated glomerulonephritis.
    Kanaguchi Y, Suzuki Y, Osaki K, Sugaya T, Horikoshi S, Tomino Y.
    Nephrol Dial Transplant; 2011 Nov 15; 26(11):3465-73. PubMed ID: 21525165
    [Abstract] [Full Text] [Related]

  • 13. Renoprotective effects of voluntary running exercise training on aldosterone-induced renal injury in human L-FABP chromosomal transgenic mice.
    Kosaki K, Sugaya T, Ohata K, Tanabe J, Hoshino S, Inoue K, Kimura K, Maeda S, Shibagaki Y, Kamijo-Ikemori A.
    Hypertens Res; 2019 Oct 15; 42(10):1518-1527. PubMed ID: 31168059
    [Abstract] [Full Text] [Related]

  • 14. Urinary excretion of liver type fatty acid binding protein accurately reflects the degree of tubulointerstitial damage.
    Yokoyama T, Kamijo-Ikemori A, Sugaya T, Hoshino S, Yasuda T, Kimura K.
    Am J Pathol; 2009 Jun 15; 174(6):2096-106. PubMed ID: 19435794
    [Abstract] [Full Text] [Related]

  • 15. Renoprotective effect of the xanthine oxidoreductase inhibitor Topiroxostat under decreased angiotensin II type 1a receptor expression.
    Ohata K, Kamijo-Ikemori A, Sugaya T, Hibi C, Nakamura T, Murase T, Oikawa T, Hoshino S, Katayama K, Asano J, Kimura K, Shibagaki Y.
    Eur J Pharmacol; 2017 Nov 15; 815():88-97. PubMed ID: 28888756
    [Abstract] [Full Text] [Related]

  • 16. Roles of human liver type fatty acid binding protein in kidney disease clarified using hL-FABP chromosomal transgenic mice.
    Kamijo-Ikemori A, Sugaya T, Matsui K, Yokoyama T, Kimura K.
    Nephrology (Carlton); 2011 Aug 15; 16(6):539-44. PubMed ID: 21504508
    [Abstract] [Full Text] [Related]

  • 17. Plasminogen activator inhibitor-1 deficiency protects against aldosterone-induced glomerular injury.
    Ma J, Weisberg A, Griffin JP, Vaughan DE, Fogo AB, Brown NJ.
    Kidney Int; 2006 Mar 15; 69(6):1064-72. PubMed ID: 16528256
    [Abstract] [Full Text] [Related]

  • 18. Increased oxidative stress, the renin-angiotensin system, and sympathetic overactivation induce hypertension in kidney androgen-regulated protein transgenic mice.
    Grande MT, Pascual G, Riolobos AS, Clemente-Lorenzo M, Bardaji B, Barreiro L, Tornavaca O, Meseguer A, López-Novoa JM.
    Free Radic Biol Med; 2011 Nov 15; 51(10):1831-41. PubMed ID: 21906672
    [Abstract] [Full Text] [Related]

  • 19. [Urinary L-type fatty acid binding protein (L-FABP) as a new urinary biomarker promulgated by the Ministry of Health, Labour and Welfare in Japan].
    Kamijo-Ikemori A, Ichikawa D, Matsui K, Yokoyama T, Sugaya T, Kimura K.
    Rinsho Byori; 2013 Jul 15; 61(7):635-40. PubMed ID: 24205707
    [Abstract] [Full Text] [Related]

  • 20. Renoprotective effect of the xanthine oxidoreductase inhibitor topiroxostat on adenine-induced renal injury.
    Kamijo-Ikemori A, Sugaya T, Hibi C, Nakamura T, Murase T, Oikawa T, Hoshino S, Hisamichi M, Hirata K, Kimura K, Shibagaki Y.
    Am J Physiol Renal Physiol; 2016 Jun 01; 310(11):F1366-76. PubMed ID: 27029427
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.